Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Effecty vs Eve

By GLP-1 ScorecardUpdated

EffectyFactor scores not reassessed.
Site position #21

Higher score

EveFactor scores not reassessed.
Site position #206

Lower score

Score comparison

Effecty has the higher recorded score — 83.7/100 to 66.3/100.

Effecty grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Separate compounded/branded offers; confirm discounts, billing and exit terms.

Before you choose

Eve does not publish a semaglutide price, so its Eve review sets out what it does disclose, while the Effecty review explains the conditions attached to Effecty's figure. The semaglutide cost page compares published rates across the field. Ask Eve for a written total before treating either one as the cheaper choice.

If neither one fits, Effecty vs Evernow and Eve vs Gala Health compare each of them with another graded program, and the list of alternatives to Effecty ranks the programs closest to Effecty on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the HealthRX review covers one graded close to these two, at 77.5/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueEffecty +25
80
55
Dose & formulationEve +4
84
88
Clinical oversightEffecty +6
85
79
Labs & monitoringEffecty +32
84
52
FulfillmentEffecty +20
87
67
Contract termsEffecty +45
86
41
Effecty · top barEve · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricEffectyEve
WeighScore83.7/10066.3/100
GradeBC
Site position#21#206
Semaglutide$170/month before code; advertised $95 first month. Supply unconfirmed.Current price not verified
Tirzepatide$235/month before code; advertised $160 first month. Supply unconfirmed.Current price not verified
CoverageNationwide shipping claimed; confirm treatment-specific eligibility.Confirm coverage for your state
Brand-name accessYesYes
Oral / sublingualNot confirmedNot confirmed
Effecty

Site position #21 · B

Factor scores not reassessed.

Strengths

  • Medication-specific billing terms
  • Dose-independent pricing advertised
  • Separate Wegovy offer published

What to consider

  • Selected total/supply unconfirmed
  • Prescription sales described as final
  • Assigned pharmacy and individual credentials unverified
Eve

Site position #206 · C

Factor scores not reassessed.

Strengths

  • Homepage lists Wegovy, Ozempic and Mounjaro
  • Terms identify Eve Health, Inc. and describe third-party care

What to consider

  • Current compounded prices and plan-specific cancellation terms remain unverified

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard